Dudediligence.

Standard BioTools Inc

LABNASDAQ · Laboratory Analytical Instruments
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$22.1MSep ’24$24.8MDec ’24$20.2MMar ’25$21.8MJun ’25$19.6MSep ’25$23.8MDec ’25$21.1MMar ’26$20.1MJun ’26
Net income, by quarter
−$26.9MSep ’24−$34.1MDec ’24−$26.0MMar ’25−$33.5MJun ’25−$34.7MSep ’25$19.3MDec ’25$127.1MMar ’26−$26.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$130.6M$97.9M$106.3M$91.0M$85.3M
Gross profitnone on file$37.1M$50.5M$44.9M$42.5M
Operating income−$67.5M−$116.2M−$76.6M−$127.5M−$110.2M
Net income−$59.2M−$190.1M−$74.7M−$138.9M−$74.9M
Operating cash flow−$44.1M−$89.4M−$43.3M−$143.5M−$74.3M
Free cash flow−$57.3M−$93.2M−$46.1M−$151.8M−$82.6M
Cash$28.5M$81.3M$51.7M$166.7M$120.9M
Debtnone on file$64.9M$63.5M$299,000none on file
Shares outstanding76.9M79.5M80.2M377.5M386.4M
LAB fundamentals · DudeDiligence